Yondelis Inicia la Fase II in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus .

Dicho ensayo lo lleva :
Gynecologic Oncology Group
National Cancer Institute (NCI)
y de momento se ha iniciado en 6 Hospitales de EEUU .

Study ID Numbers: CDR0000502192; GOG-0087M
Last Updated: September 18, 2007
Record first received: September 19, 2006
ClinicalTrials.gov Identifier: NCT00379145
Health Authority: Unspecified
ClinicalTrials.gov processed this record on September 21, 2007